Kathleen had two uneventful days. Mike was crushed by a response from the president of Neurohealing who said that though he believed and hoped that NH001 could help Kathleen, his company had been given a strict protocol to adhere to for its Phase II clinical trial. That trial could include only those with traumatic brain injury rather than anoxic injury. As always, the bulk of the research goes toward traumatic injury with little if anything supporting those with anoxic injury. Thus, the Davey's venture to encourage such research by the creation of the Global Ischemia Foundation to promote such study is even more important.
Kathleen's mom has initiated a number of long distance reiki healing sessions by people across the globe. Letters are coming in from as far away as Australia.
Kathleen had two good but uneventful days.